Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.
Journal: BJC reports
Published: January 04, 2024
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma.
Journal: Cancer research
Published: December 10, 2023
Enhancing CAR-T Cell Metabolism to Overcome Hypoxic Conditions in the Brain Tumor Microenvironment.
Journal: bioRxiv : the preprint server for biology
Published: November 28, 2023
Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment.
Journal: JCI insight
Published: November 13, 2023
Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response.
Journal: Immunity
Published: June 09, 2020
ASO Author Reflections: Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Journal: Annals of surgical oncology
Published: May 15, 2020
Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Journal: Annals of surgical oncology
Published: February 23, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026